Skip to main content
FinSpry Logo
FinSpry
PYXS logo
PYXS
(NASDAQ)
Pyxis Oncology, Inc.
$1.48-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Pyxis Oncology (PYXS) Stock Price & Financial Analysis

Pyxis Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.40 - $1.50
52-Week High$5.55
52-Week Low$0.83
Open$1.43
Volume195.74K
Average Volume (3M)195.74K
Market Cap92.58M
Shares Outstanding62.56M
Price to Sales (P/S)32.61
Price to Book (P/B)1.34
EV/EBITDA-1.23
Revenue (TTM)2.82M
Net Income (TTM)-97.09M
Free Cash Flow (TTM)-72.37M
EPS (TTM)$-1.55
Profit Margin-3442.77%
Operating Margin-3022.34%
Return on Equity (ROE)-141.16%
Debt to Equity0.28
50-Day MA$1.48
200-Day MA$2.12
52-Week Change60.66%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Pyxis Oncology

What is the current stock price for PYXS?

As of the latest trading session, PYXS stock trades at $1.48. The 52-week range is $0.83–$5.55, with a day range of $1.40–$1.50.

What is the P/E ratio for PYXS?

The P/E ratio (Price-to-Earnings) for PYXS is shown in the Key Statistics section. This valuation metric helps compare Pyxis Oncology, Inc. to industry peers.

Does PYXS pay dividends?

Pyxis Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PYXS?

Based on 2 analysts, the consensus for PYXS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PYXS?

Pyxis Oncology's market capitalization is $92.6M, classifying it as a micro-cap company. Pyxis Oncology operates in the Healthcare sector within the Biotechnology industry.